Keyword Suggestion
Domain Informations
Bacainntherapeutics.com lookup results from whois.godaddy.com server:
- Domain created: 2019-09-26T13:05:36Z
- Domain updated: 2023-09-27T15:17:57Z
- Domain expires: 2024-09-26T13:05:36Z 0 Years, 299 Days left
- Website age: 4 Years, 66 Days
- Registrar Domain ID: 2437388245_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- INES.NS.CLOUDFLARE.COM
- TERIN.NS.CLOUDFLARE.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.21.16.246
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.21.16.246)
Spam Check (IP: 104.21.16.246)
Email address with bacainntherapeutics.com
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
Recent Searched Sites
› Provo.mtc.byu.edu (26 seconds ago) / US
› Eddirasa.com (27 seconds ago) / FR
› Deporpress.com (43 seconds ago) / US
› Igraduate.co (4 seconds ago) / US
› Houstonhealth.org (18 seconds ago) / US
› Cheapenergy24.de (32 seconds ago) / DE
› Taylorprune.com (26 seconds ago) / KR
› Stacks.cdc.gov (35 seconds ago) / US
› Among-us.wtf (18 seconds ago) / US
› Bacainntherapeutics.com (12 seconds ago) / US
› Geshuiba.com (20 seconds ago) / HK
› One.network (1 seconds ago) / US
› Active-bear-fh9rr5.mystrikingly.com (23 seconds ago) / US
› Elevensports.pt (44 seconds ago) / US
› Farmaghezzo.it (11 seconds ago) / IT
› Catnight.ru (22 seconds ago) / US
› Skbcases.cn (2 seconds ago) / CN
› Y-g7.com (13 seconds ago) / US
› Yts.homes (8 seconds ago) / US
› Zococity.es (38 seconds ago) / CA
Websites Listing
We found Websites Listing below when search with bacainntherapeutics.com on Search Engine
Contact - Bacainn Therapeutics
CONTACT Have a question? Interested in collaborating with us? [email protected] 530 Virginia Road, Suite 300 Concord, MA 01742 Clinical Trials Have a question about our clinical trials? Get in touch on [email protected] or through the contact form on this page.
Bacainntherapeutics.comBacainn Therapeutics | Company Email | Telephone | Contact ...
Contact details (email, telephone numbers etc.) for Bacainn Therapeutics
Pharmacompass.comBacainn Therapeutics email format | Bacainn Therapeutics ...
Bacainn Therapeutics use these email formats. Get emails and phone number of Bacainn Therapeutics employees.
Data.aeroleads.comOur Science - Bacainn Therapeutics
Bacainn’s lead candidate, BT051, is a novel gut-restricted inhibitor of MRP2/FPR1. BT051 is designed to treat the source of chronic IBD inflammation by directly restoring healthy levels of neutrophil and epithelial cell pro-inflammatory activation, and indirectly via limiting T cell activati on. Our clinical studies are designed to investigate whether BT051 engagement with these …
Bacainntherapeutics.comExpanded Access Policy - Bacainn Therapeutics
Expanded Access Policy Bacainn Therapeutics USA, Inc. is advancing latest discoveries to develop safe and effective oral small molecules that have the potential to transform the lives of patients suffering from conditions driven by dysregulated immune cells. We are committed to bringing these important and innovative products to patients, and we believe in collaborating
Bacainntherapeutics.comContact Us - AXONIS Therapeutics
AXONIS Therapeutics, Inc.
Axonis.usCheryl Cormier - Administrat.. - Bacainn Therapeutics ...
2021-10-01 · View Cheryl Cormier's business profile as Administration Senior Manager, Business at Bacainn Therapeutics. Find contact's direct phone …
Zoominfo.comContact - Artugen Therapeutics
[email protected] 530 Virginia Road, Suite 300 Concord, MA 01742. Follow us on LinkedIn. Clinical Trials. Have a question about our clinical trials? Get in touch on [email protected] or through the contact form on this page. × . For privacy reasons Google Maps needs your permission to be loaded. For more details, please see our ...
Artugentherapeutics.comBacainn Therapeutics Company Profile | Management and ...
Bacainn Therapeutics is developing novel therapies that target the innate immune system to address uncontrolled inflammation in serious gastrointestinal and respiratory diseases. The company embraces the latest insights into innate immunity to guide bold, new approaches for treating inflammatory diseases differently. Founded in 2017, Bacainn is funded by Morningside …
Datanyze.comBacainn Therapeutics Announces IND Clearance for BT051 and ...
2020-06-09 · About Bacainn Therapeutics Bacainn Therapeutics is a spin-out company from University of Massachusetts Medical School and is based on the extensive insights into neutrophil biology generated by Dr ...
Businesswire.comBacainn Therapeutics - LinkedIn
Bacainn Therapeutics. 187 followers. 3mo. Report this post. Join Ashley Mansell at the 3rd Inflammasome Therapeutics Summit where he is presenting on BT032, Bacainn's novel dual NLRP1 and NLRP3 ...
Linkedin.comHome — Artugen Therapeutics
Artugen is harnessing recent advances in microbiome science to identify novel Live Biotherapeutic Products to help patients living with infectious, …
Artugentherapeutics.comChristopher Murphy - Vice Pr.. - Bacainn Therapeutics ...
2021-12-22 · View Christopher Murphy's business profile as Vice President, Research & Development at Bacainn Therapeutics. Find contact's direct phone number, email address, work history, and more.
Zoominfo.comChristopher Murphy - Vice Pr.. - Bacainn Therapeutics ...
2021-12-22 · View Christopher Murphy's business profile as Vice President, Research & Development at Bacainn Therapeutics. Find contact's direct phone number, email address, work history, and more.
Zoominfo.comBacainn Therapeutics | VentureRadar
"Bacainn approaches inflammation differently in gastrointestinal and respiratory diseases In exploring novel approaches for ulcerative colitis, Bacainn looked beyond the role of T Cells in inflammation to see the potential of blocking neutrophil accumulation and activity in the colon.
Ventureradar.combacainntherapeutics.com Home - Bacainn Therapeutics
Bacainntherapeutics.com registered under .COM top-level domain. Check other websites in .COM zone. The last verification results, performed on (November 06, 2020) bacainntherapeutics.com show that bacainntherapeutics.com has a valid and up-to-date SSL certificate issued by CloudFlare, Inc. expiring on August 04, 2021. Click “Refresh” button for …
Webrate.orgBacainn Therapeutics’ Ashley Mansell to Present on BT032 ...
2021-11-12 · Bacainn Therapeutics is developing novel therapies that target the innate immune system to address uncontrolled inflammation. The company was …
Finance.yahoo.comBacainn Therapeutics Presents at ECCO ‘21 Results from ...
2021-07-09 · CONCORD, Mass., July 09, 2021--Bacainn Therapeutics, Inc., a biotechnology company focused on developing novel therapies that target the innate immune system to address uncontrolled inflammation ...
Finance.yahoo.comBacainn Therapeutics' Ashley Mansell to Present on BT032 ...
2021-11-12 · Bacainn Therapeutics is developing novel therapies that target the innate immune system to address uncontrolled inflammation. The company was …
Benzinga.comBacainn Therapeutics’ Ashley Mansell to Present on BT032 ...
2021-11-12 · CONCORD, Mass., November 12, 2021--Bacainn Therapeutics, Inc., a biotechnology company focused on developing novel therapies that target the innate immune system to address uncontrolled inflammation, today announced that Ashley Mansell, PhD, Senior Director of Research & Development, Bacainn Therapeutics & Principal Investigator, Hudson …
Ca.movies.yahoo.com
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
craigwalker.net | domain.com | -1 Years, -72 Days |
infi-star-nity.com | netowl.jp | -1 Years, -11 Days |
sendaipress.com | gmo.jp | -1 Years, -270 Days |
speedishuttle.com | godaddy.com | -1 Years, -71 Days |
helolyrics.com | namecheap.com | -1 Years, -273 Days |
rustleryachts.com | register.com | -1 Years, -101 Days |
xinvang.org | gkg.net | -1 Years, -194 Days |
firegroup.io | godaddy.com | -1 Years, -23 Days |
kuribl.com | godaddy.com | -1 Years, -244 Days |
neopetsclassic.com | namecheap.com | 17 Days |